Propylthiouracil
Propylthiouracil.JPG

CLINICAL USE

Hyperthyroidism

DOSE IN NORMAL RENAL FUNCTION

Initially: 200–400 mg dailyMaintenance dose: 50–150 mg daily

PHARMACOKINETICS

  • Molecular weight                           :170.2
  • %Protein binding                           :80
  • %Excreted unchanged in urine     : <2
  • Volume of distribution (L/kg)       :0.3–0.4
  • half-life – normal/ESRD (hrs)      :1–2/8.5

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : 75% of normal dose and titrate to response
  • <10           : 50% of normal dose and titrate to response

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unknown dialysability. Dose as in GFR <10 mL/min
  • HD                     :Not dialysed. Dose as in GFR <10 mL/min
  • HDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min
  • CAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • None known

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Renally impaired patients are at a greater risk of cardiotoxicity and leucopenia.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs